Lut Overbergh
Overview
Explore the profile of Lut Overbergh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
2355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moulder R, Hirvonen M, Valikangas T, Suomi T, Overbergh L, Peakman M, et al.
Diabetologia
. 2025 Feb;
PMID: 40019499
Aims/hypothesis: While investigating markers for declining beta cell function in type 1 diabetes, we previously demonstrated 11 statistically significant protein associations with fasting C-peptide/glucose ratios in longitudinal serum samples from...
2.
Hoffmann L, Kohls M, Arnolds S, Achenbach P, Bergholdt R, Bonifacio E, et al.
BMJ Open
. 2025 Jan;
15(1):e088522.
PMID: 39753267
Introduction: The identification of type 1 diabetes at an early presymptomatic stage has clinical benefits. These include a reduced risk of diabetic ketoacidosis (DKA) at the clinical manifestation of the...
3.
Mallone R, Sims E, Achenbach P, Mathieu C, Pugliese A, Atkinson M, et al.
Diabetes
. 2024 Oct;
74(1):12-21.
PMID: 39446565
Article Highlights:
4.
Almagro Armenteros J, Brorsson C, Johansen C, Banasik K, Mazzoni G, Moulder R, et al.
Diabetes Metab Res Rev
. 2024 Jul;
40(5):e3833.
PMID: 38961656
Aims: Heterogeneity in the rate of β-cell loss in newly diagnosed type 1 diabetes patients is poorly understood and creates a barrier to designing and interpreting disease-modifying clinical trials. Integrative...
5.
Sebastiani G, Grieco G, Bruttini M, Auddino S, Mori A, Toniolli M, et al.
Cell Rep Med
. 2024 Jun;
5(6):101591.
PMID: 38838677
Circulating microRNAs (miRNAs) are linked to the onset and progression of type 1 diabetes mellitus (T1DM), thus representing potential disease biomarkers. In this study, we employed a multiplatform sequencing approach...
6.
Vatanen T, de Beaufort C, Marcovecchio M, Overbergh L, Brunak S, Peakman M, et al.
Diabetologia
. 2024 Jun;
67(9):1930-1942.
PMID: 38832971
Aims/hypothesis: The gut microbiome is implicated in the disease process leading to clinical type 1 diabetes, but less is known about potential changes in the gut microbiome after the diagnosis...
7.
Marcovecchio M, Hendriks A, Delfin C, Battelino T, Danne T, Evans M, et al.
Diabetologia
. 2024 Mar;
67(6):995-1008.
PMID: 38517484
Aims/hypothesis: Type 1 diabetes is an heterogenous condition. Characterising factors explaining differences in an individual's clinical course and treatment response will have important clinical and research implications. Our aim was...
8.
Callebaut A, Guyer P, Derua R, Buitinga M, Manganaro A, Yi X, et al.
Diabetes
. 2024 Feb;
73(5):728-742.
PMID: 38387030
Article Highlights:
9.
Callebaut A, Guyer P, Baker R, Gallegos J, Hohenstein A, Gottlieb P, et al.
Diabetes
. 2024 Jan;
73(5):743-750.
PMID: 38295386
Article Highlights:
10.
Moulder R, Valikangas T, Hirvonen M, Suomi T, Brorsson C, Lietzen N, et al.
Diabetologia
. 2023 Aug;
66(11):1983-1996.
PMID: 37537394
Aims/hypothesis: There is a growing need for markers that could help indicate the decline in beta cell function and recognise the need and efficacy of intervention in type 1 diabetes....